Back to Browse Journals » Patient Preference and Adherence » Volume 5

Patient preferences in the treatment of diabetic retinopathy

Authors Wirostko B, Beusterien K, Grinspan J, Ciulla T, Gonder J, Barsdorf A, Pleil A

Published Date May 2011 Volume 2011:5 Pages 229—237

DOI http://dx.doi.org/10.2147/PPA.S11972

Published 24 May 2011

Barbara Wirostko1, Kathleen Beusterien2, Jessica Grinspan2, Thomas Ciulla3, John Gonder4, Alexandra Barsdorf1, Andreas Pleil5
1Pfizer, New York, NY, USA; 2Oxford Outcomes, Bethesda, MD, USA; 3Midwest Eye Institute, Indianapolis, IN, USA; 4Ivey Eye Institute, London, Ontario, Canada; 5Pfizer Inc, San Diego, CA, USA

Objective: Accounting for patient preferences may be especially important in diabetes mellitus, given the challenge in identifying factors associated with treatment adherence. Although preference studies have been performed in diabetes, none have examined treatments used in diabetic retinopathy (DR). The objective of this study was to elicit patient preferences for attributes associated with antivascular endothelial growth factor, focal and panretinal laser, and steroid therapy used in DR management.
Methods: A cross-sectional conjoint survey was administered to DR patients at three Canadian eye centers. The survey involved making tradeoffs among 11 DR treatment attributes, including the chance of improving vision and risks of adverse events over a 1-year treatment period. Attribute utilities were summed for each product profile to determine the most preferred treatment.
Results: Based on the results from 161 patients, attributes affecting visual functioning, including improving visual acuity and reducing adverse events (eg, chance of cataracts), were more important than those not directly affecting vision (eg, administration). Overall, 52%, 20%, 17%, and 11% preferred the product profiles matching to the antivascular endothelial growth factor, steroid, focal laser, and panretinal laser therapies. Preferences did not vary substantially by previous treatment experience, age, or type of DR (macular edema, proliferative DR, both or neither), with the exception that more macular edema only patients preferred focal laser over steroid treatment (19% versus 14%, respectively).
Conclusions: When considering the potential effects of treatment over a 1-year period, treatment preferences in DR are most influenced by those that may positively or negatively affect visual functioning.

Keywords: diabetes, retinopathy, patient preference, ophthalmology, conjoint analysis

Download Article [PDF] View Full Text [HTML] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

Assessment of patient preference in allocation and observation of anti-tuberculosis medication in three districts in Tanzania

Saidi Egwaga, Nyagosya Range, Fred Lwilla, Abdallah Mkopi, Vivien Barongo, et al

Patient Preference and Adherence 2008, 2:1-6

Published Date: 5 February 2008

Patient knowledge and perception of upper respiratory infections, antibiotic indications and resistance

Frank A Filipetto, Danesh S Modi, Lucia Beck Weiss, Carman A Ciervo

Patient Preference and Adherence 2008, 2:35-39

Published Date: 24 February 2008

Preference for and adherence to oral phosphodiesterase-5 inhibitors in the treatment of erectile dysfunction

Konstantinos Giannitsas, Angelis Konstantinopoulos, Christos Patsialas, Petros Perimenis

Patient Preference and Adherence 2008, 2:149-155

Published Date: 23 April 2008

Drug use and barriers to and facilitators of drug treatment for homeless youth

Adeline Nyamathi, Angela Hudson, Malaika Mutere, Ashley Christiani, Jeff Sweat, Kamala Nyamathi, Theresa Broms

Patient Preference and Adherence 2007, 1:1-8

Published Date: 24 October 2007

Gold nanoparticles: From nanomedicine to nanosensing

Po C Chen, Sandra C Mwakwari, Adegboyega K Oyelere

Nanotechnology, Science and Applications 2008, 1:45-66

Published Date: 2 November 2008

Brief report: Characteristics of antidepressant use in patients with heart failure

Paul J Mills, Joel E Dimsdale, Suzi Hong, Geoffrey Van Den Brande, Laura Redwine, et al

Patient Preference and Adherence 2008, 2:333-336

Published Date: 11 November 2008

Clinical applications of the sustained-release dexamethasone implant for treatment of macular edema

Rocío Herrero-Vanrell, Jose Augusto Cardillo, Baruch D Kuppermann

Clinical Ophthalmology 2011, 5:139-146

Published Date: 1 February 2011